Privium Fund Management (UK)’s Kindred Biosciences, Inc. KIN Stock Holding History

Privium Fund Management (UK)’s Portfolio KIN Stock Details KIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-90,000	Closed	-$825K	–	91
2021 Q2	$825K	Buy	+90,000	New	+$524K	0.57%	35

Other funds holding KIN

CFO

CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return

Privium Fund Management (UK)'s KIN Position: Q3 2021 in Review

Privium Fund Management (UK) sold out of Kindred Biosciences, Inc. (KIN) in Q3 2021, closing a stake of 90,000 shares — an estimated $825K sold.

Privium Fund Management (UK) first reported a position in KIN in Q2 2021 and held it in 1 quarter. The position peaked at $825K in Q2 2021. 1 fund tracked by Wall St. Rank holds KIN as of Q3 2021.

Privium Fund Management (UK) reported no remaining Kindred Biosciences, Inc. position as of Q3 2021 after selling out during the quarter.
Privium Fund Management (UK) sold 90,000 Kindred Biosciences, Inc. shares in Q3 2021, an estimated $825K.
Privium Fund Management (UK) first reported a position in Kindred Biosciences, Inc. in Q2 2021 and held it in 1 quarter.
Privium Fund Management (UK)'s Kindred Biosciences, Inc. position peaked at $825K in Q2 2021.
1 fund tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q3 2021.

Based on Privium Fund Management (UK)'s 13F filing for Q3 2021, filed 5 Nov 2021.